fig2

Multimodal 4-arylchromene derivatives with microtubule-destabilizing, anti-angiogenic, and MYB-inhibitory activities

Figure 2. Cell cycle events of 518A2 melanoma cells treated with 2A-C and 2F (25 nM) for 24 h. Positive control (C-A4) and solvent (DMSO) were treated similarly to the substances. Measurements were carried out in triplicate and expressed as means ± SD with GraphPad Prism. Significance is expressed as n.s. P > 0.05; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001 against control (two-way ANOVA, with Dunnett’s multiple comparison test).

Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/